TTURC Project Coordinator

Tobacco Use Research Center
2701 University Avenue SE
Suite 201
Minneapolis, MN 55414
Office: (612) 627-4903

Ms. Jensen coordinates the overall TTURC project, including administration of Dorothy Hatsukami's research projects and is responsible for regulatory oversight for the TTURC. She has worked in the tobacco research area for the past 17 years.

Selected Recent Publications

1. Hecht SS, Carmella SG, Yoder A, Chen M, Li ZZ, Le C, Dayton R, Jensen J, and Hatsukami DK. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiology, Biomarkers and Prevention. 2006;15(10):1805-1811.
2. Stepanov I, Jensen J, Hatsukami D, and Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine & Tobacco Research. 2006;8(2):309-313.
3. Hatsukami DK, Kotlyar M, Allen S, Jensen J, Li S, Le C, and Murphy S. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128(4):2528-2537.
4. Hecht SS, Chen M, Yoder A, Jensen J, Hatsukami D, Le C, and Carmella SG. Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(12): 2969-2974.
5. Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, and Hatsukami DK. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(3):693-698.
6. Lemmonds CA, Hecht SS, Jensen JA, Murphy SE, Carmella SG, Zhang Y, and Hatsukami DK. Smokeless tobacco topography and toxin exposure. Nicotine & Tobacco Research. 2005;7(3):469-474.
7. Mooney M, Babb D, Jensen J, and Hatsukami D. Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial. Nicotine & Tobacco Research. 2005;7(4):565-579.
8. Hecht SS, Carmella SG, Le KA, Murphy SE, Li YS, Le C, Jensen J, and Hatsukami DK. Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. Cancer Epidemiology, Biomarkers and Prevention. 2004;13(5):834-842.
9. Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, and Hatsukami DK. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. Journal of the National Cancer Institute. 2004;96(2):107-115.
10. Hatsukami DK, Edmonds A, Schulte S, Jensen J, Le CT, Losey L, Carmella SG, and Hecht SS. Preliminary study on reducing oral moist snuff use. Drug and Alcohol Dependence. 2003;70(2):215-220.
11. Hatsukami DK, Jensen J, Brauer LH, Mooney M, Schulte S, Sofuoglu M, and Pentel PR. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine. Pharmacology, Biochemistry and Behavior. 2003;75(1):1-7.
12. Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, and Hatsukami DK. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Research. 2002;62(1):129-134.